Opinion: Learning from Immunotherapy’s Recent Failures
Opinion: Learning from Immunotherapy’s Recent Failures
The promise of immunotherapy is real. We now need to figure out how to maximize the number of patients the approach benefits.
Opinion: Learning from Immunotherapy’s Recent Failures
Opinion: Learning from Immunotherapy’s Recent Failures

The promise of immunotherapy is real. We now need to figure out how to maximize the number of patients the approach benefits.

The promise of immunotherapy is real. We now need to figure out how to maximize the number of patients the approach benefits.

turkey, genetics & genomics, culture, disease & medicine
Officially Intelligent
Officially Intelligent
Bob Grant | Aug 1, 2018
Humanity is on the precipice of major change. Some fear a world ruled by bots. I fear a world ruled by people.
Lessons from Biosphere 2
Lessons from Biosphere 2
Mark Nelson | Aug 1, 2018
Both the scientific community and the general public still have a lot to learn from the largest mesocosm research project ever conducted.
CRISPR Inches Toward the Clinic
CRISPR Inches Toward the Clinic
Shawna Williams | Aug 1, 2018
The gene-editing technology is already in trials for some rare conditions, with more human testing on the horizon.
New Species of Ebola Discovered
New Species of Ebola Discovered
Catherine Offord | Jul 31, 2018
The Bombali Ebola virus was identified in bats in Sierra Leone, and there’s no evidence that it has infected people or causes human disease.
Monkeys Pass on Brain Activity Patterns Linked to Anxiety
Monkeys Pass on Brain Activity Patterns Linked to Anxiety
Ashley Yeager | Jul 30, 2018
Humans might also inherit such brain changes, a new study suggests.
UK to Legalize Medicinal Cannabis
UK to Legalize Medicinal Cannabis
Catherine Offord | Jul 27, 2018
Patients will be able to access the drug with a prescription, and there are no plans to allow for recreational use.
Alzheimer’s Drug Slows Symptoms, Reduces Plaques
Alzheimer’s Drug Slows Symptoms, Reduces Plaques
Kerry Grens | Jul 26, 2018
In a clinical trial, patients on the highest injected dose had 30 percent less cognitive decline over time than people on a placebo.
Ultrasound Opens Blood-Brain Barrier in Alzheimer’s Patients
Ultrasound Opens Blood-Brain Barrier in Alzheimer’s Patients
Ashley Yeager | Jul 26, 2018
A Phase 1 clinical trial shows the noninvasive technique is safe and could aid in the delivery treatments to the brain.
Genes Explain About 11 Percent of Differences in Years of Education
Genes Explain About 11 Percent of Differences in Years of Education
Shawna Williams | Jul 24, 2018
The influence of genetic variants tops that of socioeconomic status.